H
VRTX icon

HoyleCohen’s Vertex Pharmaceuticals VRTX Stock Holding History

HoyleCohen’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$338K Buy
+722
New +$313K 0.03% 216
2024
Q1 		– Sell
-528
Closed -$215K – 285
2023
Q4 		$215K Buy
+528
New +$195K 0.02% 257

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

HoyleCohen's VRTX Position: Q2 2024 in Review

HoyleCohen opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2024: 722 shares worth $338K. The stake represents 0.03% of the portfolio and ranks #216 among its holdings. This is a return to the name: HoyleCohen previously reported a position in VRTX as recently as Q4 2023.

HoyleCohen first reported a position in VRTX in Q4 2023 and has held it in 2 quarters since. 1,546 funds tracked by Wall St. Rank hold VRTX as of Q2 2024.

  • HoyleCohen held 722 shares of Vertex Pharmaceuticals worth $338K as of Q2 2024.
  • Vertex Pharmaceuticals was a new HoyleCohen position in Q2 2024.
  • Vertex Pharmaceuticals made up 0.03% of HoyleCohen's portfolio in Q2 2024, its #216 holding.
  • HoyleCohen first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • 1,546 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2024.

Based on HoyleCohen's 13F filing for Q2 2024, filed 19 Jul 2024.